Key facts
- Emit Imaging’s last known valuation is $23.9M (Apr 2023).
- It has raised $20.0M across 1 recorded rounds; the latest was Early Stage VC ($7.1M) in Sep 2024.
- Emit Imaging has filed 2 Form Ds with the SEC since 2024, most recently Jul 2025 ($7.1M sold to 17 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·Watchlist + deal alerts for Emit Imaging
Funding rounds
1 roundsAbout Emit Imaging
Developer of an imaging technology designed to monitor drug distribution and protein expression. The company's technology includes features such as configurable white light and fluorescence imaging, flexible sample imaging parameters, onboard data handling and study monitoring, image analysis, and quantification, enabling pharmaceutical, biotechnology, and academic researchers to advance scientific and medical research.
- Sector
- Healthcare
- HQ
- Boston, MA, United States
- Founded
- 2018
- Employees
- 25
- Website
- emitimaging.com/
- Ownership
- Privately Held (backing)
Emit Imaging doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Emit Imaging shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Emit Imaging in its N-PORT filings yet. We sweep new filings monthly.